RadNet (RDNT) Surges: Stock Moves 21.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:21AM CDT
RadNet, Inc. (RDNT) was a big mover last session, as the company saw its shares rise by almost 22% on the day.
Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
GlobeNewswire - Fri May 09, 3:05PM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast:
Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
GlobeNewswire - Fri May 02, 3:05PM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the company will hold its annual shareholders meeting on May 7, 2014 at 9:00 a.m. (EDT) at the company headquarters in Ann Arbor, Michigan. Shareholders of record as of March 11, 2014 are entitled to notice of and to vote at the meeting.
Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:44AM CDT
Prothena Corporation plc (PRTA) was a big mover last session, as the company saw its shares rally nearly 10.00% on the day.
Upcoming Conference Calls, Commencement of Shipments, Stock Price Movements, Awareness Campaigns, and Acquisitions - Analyst Notes on Incyte, Impax, ANI, Ironwood and Aastrom
PR Newswire - Thu Apr 24, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Incyte Corporation (NASDAQ: INCY), Impax Laboratories Inc. (NASDAQ: IPXL), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) and Aastrom Biosciences, Inc. (NASDAQ: ASTM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1519-100free.
Centene (CNC) Soars: Stock Adds 12.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:57AM CDT
Centene Corp. (CNC) was a big mover last session, as the company saw its shares rise over 12% on the day.
Allergan Inc. (AGN) in Focus: Stock Rallies 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:44AM CDT
Allergan Inc. was a big mover last session, as the company saw its shares surge over 15.0% on the day.
ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:44AM CDT
ANI Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge nearly 21% on the day.
Aastrom to buy USD6.5m Cell Therapy and Regenerative Medicine business from Sanofi
M2 - Tue Apr 22, 6:12AM CDT
Nulticellular therapies company Aastrom Biosciences (NasdaqCM:ASTM) revealed on Monday the launch of a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for a purchase price of USD6.5m in cash in promissory note.
Why Aastrom Biosciences (ASTM) Stock Is Soaring Today
at The Street - Mon Apr 21, 10:22AM CDT
Aastrom Biosciences (ASTM) soared Monday after the company announced its acquisition of Sanofi's Cell Therapy and Regenerative Medicine, or CTRM, business for $6.5 million. Aastrom will pay $4 million in cash and $2.5 million in a promissory note for...
Traders Get Bullish on Shares of Aastrom Biosciences, Shares Up 28.4% (ASTM)
Comtex SmarTrend(R) - Mon Apr 21, 10:10AM CDT
Aastrom Biosciences (NASDAQ:ASTM) is one of today's best performing low-priced stocks, up 28.4% to $4.52 on 2.4x average daily volume. Thus far today, Aastrom Biosciences has traded 1.6 million shares, vs. average volume of 683,000 shares per day. The stock has outperformed the Dow (28.4% to the Dow's 0.0%) and outperformed the S&P 500 (28.4% to the S&P's 0.0%) during today's trading.
Strength Seen in Retrophin, Inc. (RTRX) as Stock Shoots up 18% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 7:44AM CDT
Retrophin, Inc. was a big mover last session, as the company saw its shares surge ahead 18% on the day.
Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
GlobeNewswire - Mon Apr 21, 7:39AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has entered into a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for a purchase price of $6.5 million, with $4 million payable in cash at closing and $2.5 million payable in the form of a promissory note. The acquisition is subject to customary closing conditions and is scheduled to close in approximately three weeks.
ImmunoGen, Inc. (IMGN) in Focus: Stock Rallies 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:44AM CDT
ImmunoGen, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.
Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 % - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 7:44AM CDT
Kythera Biopharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences
PR Newswire - Mon Apr 14, 8:00AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89% to 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the 10 sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has lost 4.46% in the last one month. Investor-Edge has initiated coverage on the following equities: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Incyte Corp. Ltd (NASDAQ: INCY), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) and Aastrom Biosciences Inc. (NASDAQ: ASTM). Free technical research on ALXN, INCY, MACK and ASTM can be downloaded upon signing up at:
Baxano Surgical, Inc. (BAXS) in Focus: Stock up 10.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:44AM CDT
Baxano Surgical, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Rallies 11.06% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 11% on the day.
Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the independent Data and Safety Monitoring Board (DSMB) for the company's ixCELL-DCM Phase 2b clinical trial has recommended continuing the study without modification as planned following an interim review of unblinded safety data from the trial.
RadNet, Inc. (RDNT) in Focus: Stock Surges 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:44AM CDT
RadNet, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.